Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protoxin vs Botox in Glabellar Lines
NCT05364580Phase 3Completed
- Sponsor
- Sophiris Bio Inc.
- Start
- Mar 2023
- Primary completion
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of PROTOXIN in glabellar lines, sponsored by Sophiris Bio Inc.. Started Mar 2023; status: completed.
02
Drugs
PROTOXIN
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT05364580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05364580.